InsidersTradesSigma
Track the 沛爾生醫-創 share price and the full management transaction log of the company, a listed issuer based in Taiwan. Shares are quoted on the TW market, under the supervision of TWSE / TPEx (MOPS). Market capitalisation: €97.7bn. The latest transaction was disclosed on 22 June 2026 (Gift). Among the most active insiders: 許家慧. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Peir Biomedical-Innovation es una empresa que cotiza en el mercado XTAI, especializada en el sector de la biotecnología. Se centra en el desarrollo de soluciones innovadoras para la industria de la salud.